Lars Farde
Lars Farde
Professor of Psychiatry, Karolinska Institutet
Verified email at
Cited by
Cited by
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to …
L Farde, AL Nordström, FA Wiesel, S Pauli, C Halldin, G Sedvall
Archives of general psychiatry 49 (7), 538-544, 1992
Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET
L Farde, H Hall, E Ehrin, G Sedvall
Science 231 (4735), 258-261, 1986
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
L Farde, FA Wiesel, C Halldin, G Sedvall
Archives of general psychiatry 45 (1), 71-76, 1988
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
EG Jönsson, MM Nöthen, F Grünhage, L Farde, Y Nakashima, P Propping, ...
Molecular psychiatry 4 (3), 290-296, 1999
The correlative triad among aging, dopamine, and cognition: current status and future prospects
L Bäckman, L Nyberg, U Lindenberger, SC Li, L Farde
Neuroscience & Biobehavioral Reviews 30 (6), 791-807, 2006
Changes in cortical dopamine D1 receptor binding associated with cognitive training
F McNab, A Varrone, L Farde, A Jucaite, P Bystritsky, H Forssberg, ...
Science 323 (5915), 800-802, 2009
D2 dopamine receptors in neuroleptic-naive schizophrenic patients: a positron emission tomography study with [11C] raclopride
L Farde, FA Wiesel, S Stone-Elander, C Halldin, AL Nordström, HÅ Hall, ...
Archives of General Psychiatry 47 (3), 213-219, 1990
Age-related cognitive deficits mediated by changes in the striatal dopamine system
L Bäckman, N Ginovart, RA Dixon, TBR Wahlin, Å Wahlin, C Halldin, ...
American Journal of Psychiatry 157 (4), 635-637, 2000
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients
AL Nordström, L Farde, FA Wiesel, K Forslund, S Pauli, C Halldin, ...
Biological psychiatry 33 (4), 227-235, 1993
Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis
L Farde, L Eriksson, G Blomquist, C Halldin
Journal of Cerebral Blood Flow & Metabolism 9 (5), 696-708, 1989
Distribution of D 1-and D 2-dopamine receptors, and dopamine and its metabolites in the human brain
H Hall, G Sedvall, O Magnusson, J Kopp, C Halldin, L Farde
Neuropsychopharmacology 11 (4), 245-256, 1994
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients
AL Nordstrom, L Farde, S Nyberg, P Karlsson, C Halldin, G Sedvall
American Journal of Psychiatry 152 (10), 1444-1449, 1995
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
V Kaasinen, H Vilkman, J Hietala, K Någren, H Helenius, H Olsson, ...
Neurobiology of aging 21 (5), 683-688, 2000
D1-and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
L Farde, FA Wiesel, AL Nordström, G Sedvall
Psychopharmacology 99 (1), S28-S31, 1989
The serotonin system and spiritual experiences
J Borg, B Andrée, H Soderstrom, L Farde
American Journal of Psychiatry 160 (11), 1965-1969, 2003
No D2 receptor increase in PET study of schizophrenia
L Farde, FA Wiesel, HÅ Hall, C Halldin, S Stone-Elander, G Sedvall
Archives of General Psychiatry 44 (7), 671-672, 1987
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography
L Farde, E Ehrin, L Eriksson, T Greitz, H Hall, CG Hedström, JE Litton, ...
Proceedings of the National Academy of Sciences 82 (11), 3863-3867, 1985
PET analysis of human dopamine receptor subtypes using 11 C-SCH 23390 and 11 C-raclopride
L Farde, C Halldin, S Stone-Elander, G Sedvall
Psychopharmacology 92 (3), 278-284, 1987
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen
O Lindvall, EO Backlund, L Farde, G Sedvall, R Freedman, B Hoffer, ...
Annals of neurology 22 (4), 457-468, 1987
Suggested Minimal Effective Dose of Risperidone Based on PET-Measured D2 and 5-HT2A Receptor Occupancy in Schizophrenic Patients
S Nyberg, B Eriksson, G Oxenstierna, C Halldin, L Farde
American Journal of Psychiatry 156 (6), 869-875, 1999
The system can't perform the operation now. Try again later.
Articles 1–20